PAVmed Inc. (PAVM) Revenue History
Annual and quarterly revenue from 2014 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
PAVM Revenue Growth
Revenue Breakdown (FY 2022)
PAVM's revenue distribution by segment and geography for fiscal year 2022
By Product/Segment
PAVM Revenue Analysis (2014–2024)
As of May 8, 2026, PAVmed Inc. (PAVM) generated trailing twelve-month (TTM) revenue of $29,000, reflecting significant decline in growth of -99.5% year-over-year. The most recent quarter (Q3 2025) recorded $5,000 in revenue, down 16.7% sequentially.
Looking at the longer-term picture, PAVM's historical revenue data shows a 3-year CAGR of +81.6%. The company achieved its highest annual revenue of $3.0 million in 2024, representing a new all-time high.
Revenue diversification analysis shows PAVM's business is primarily driven by Royalty (100%). With over half of revenue concentrated in Royalty, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including NVCR (+8.5% YoY), INVA (+13.6% YoY), and MGRX (-38.2% YoY), PAVM has underperformed the peer group in terms of revenue growth. Compare PAVM vs NVCR →
PAVM Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PAVMCurrent | $29,000 | -99.5% | - | -1485.4% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 INVA | $425M | +13.6% | +4.8% | 38.5% | |
 MGRX | $615,873 | -38.2% | - | -1294.4% | |
 ATEC | $764M | -7.4% | +39.5% | -10.7% | |
 GKOS | $507M | +36.3% | +17.7% | -17.1% |
PAVM Historical Revenue Data (2014–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $3.0M | +22.1% | $-3,043,000 | -101.6% | $-44,487,000 | -1485.4% |
| 2023 | $2.5M | +550.4% | $-3,968,000 | -161.8% | $-68,795,000 | -2805.7% |
| 2022 | $377K | -24.6% | $-3,237,000 | -858.6% | $-91,087,000 | -24161.0% |
| 2021 | $500K | - | $-85,000 | -17.0% | $-54,393,000 | -10878.6% |
| 2020 | $0 | - | $0 | - | $-23,351,000 | - |
| 2019 | $0 | - | $-14,226 | - | $-14,295,295 | - |
| 2018 | $0 | - | $-9,790 | - | $-10,563,205 | - |
| 2017 | $0 | - | $-7,110 | - | $-8,034,119 | - |
| 2016 | $0 | - | $-3,793 | - | $-5,650,851 | - |
| 2015 | $0 | - | $0 | - | $-1,776,600 | - |
See PAVM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PAVM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PAVM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPAVM — Frequently Asked Questions
Quick answers to the most common questions about buying PAVM stock.
Is PAVM's revenue growth accelerating or slowing?
PAVM revenue declined -99.5% year-over-year, contrasting with the 5-year CAGR of N/A. TTM revenue fell to $29000.00. This reverses the prior growth trend.
What is PAVM's long-term revenue growth rate?
PAVmed Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of -99.5% is below this long-term average.
How is PAVM's revenue distributed by segment?
PAVM reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2024 are available for download. Segment mix reveals concentration and diversification trends.